Stealth BioTherapeutics Corp Interest Expense 2011-2026 | MITO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Stealth BioTherapeutics Corp

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.24 M	1.81 M	6.67 M	21.4 M	3.28 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
21.4 M	1.24 M	6.87 M

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
BioLineRx Ltd. BLRX	9.07 M	$ 2.25	1.81 %	$ 908 M	Israel
BioNTech SE BNTX	14.2 M	$ 91.28	0.11 %	$ 27.2 B	Germany
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Alnylam Pharmaceuticals ALNY	5.2 M	$ 330.34	3.6 %	$ 43.3 B	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Catalyst Pharmaceuticals CPRX	25.7 M	$ 24.98	1.17 %	$ 3.05 B	USA
Corbus Pharmaceuticals Holdings CRBP	1.24 M	$ 10.14	-0.29 %	$ 135 M	USA
Cardiff Oncology CRDF	5 K	$ 1.58	-	$ 106 M	USA
Curis CRIS	890 K	$ 0.53	-3.07 %	$ 6.98 M	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Crinetics Pharmaceuticals CRNX	-357 K	$ 37.7	1.26 %	$ 3.55 B	USA
CRISPR Therapeutics AG CRSP	86.6 M	$ 49.15	-0.73 %	$ 4.42 B	Schweiz
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Anavex Life Sciences Corp. AVXL	4.68 M	$ 2.96	-1.0 %	$ 252 M	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
CytomX Therapeutics CTMX	28 K	$ 4.4	-3.51 %	$ 607 M	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Citius Pharmaceuticals CTXR	10.8 K	$ 0.86	0.67 %	$ 5.79 M	USA
Cue Biopharma CUE	100 K	$ 0.18	-1.61 %	$ 17.1 M	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
Aquestive Therapeutics AQST	6.55 M	$ 4.09	-0.97 %	$ 437 M	USA
Daré Bioscience DARE	-153 K	$ 1.81	4.02 %	$ 20.2 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Arcturus Therapeutics Holdings ARCT	10.1 M	$ 8.22	2.37 %	$ 225 M	Israel
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Dyadic International DYAI	250 K	$ 0.87	-2.8 %	$ 31.5 M	USA
Celldex Therapeutics CLDX	927 K	$ 31.37	1.0 %	$ 2.08 B	USA
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA